73 related articles for article (PubMed ID: 2529961)
21. A glycosylated nitric oxide donor, beta-Gal-NONOate, and its site-specific antitumor activity.
Chen C; Shi Y; Li S; Qi Q; Gu L; Song J; Wang PG
Arch Pharm (Weinheim); 2006 Jul; 339(7):366-71. PubMed ID: 16783837
[TBL] [Abstract][Full Text] [Related]
22. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
23. Sensitization of 9L rat brain gliosarcoma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
Hung DT; Deen DF; Seidenfeld J; Marton LJ
Cancer Res; 1981 Jul; 41(7):2783-5. PubMed ID: 6788362
[TBL] [Abstract][Full Text] [Related]
24. Differential potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine in chloroethylnitrosourea-sensitive and -resistant 9L rat brain tumor cells in vitro.
Oredsson SM; Tofilon PJ; Feuerstein BG; Deen DF; Rosenblum ML; Marton LJ
Cancer Res; 1983 Aug; 43(8):3576-8. PubMed ID: 6407751
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of the effects of hyperthermia and BCNU on BCNU-sensitive and BCNU-resistant 9L rat brain tumor cells.
Da Silva V; Tofilon PJ; Gutin PH; Dewey WC; Buckley N; Deen DF
Radiat Res; 1985 Sep; 103(3):363-72. PubMed ID: 4034932
[TBL] [Abstract][Full Text] [Related]
26. Chlorozocin. A diabetogenic analogue of streptozocin with dissimilar mechanisms of action on pancreatic beta cells.
Mossman BT; Wilson GL; Craighead JE
Diabetes; 1985 Jun; 34(6):602-10. PubMed ID: 3159609
[TBL] [Abstract][Full Text] [Related]
27. Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level.
Bischof JC; Smith D; Pazhayannur PV; Manivel C; Hulbert J; Roberts KP
Cryobiology; 1997 Feb; 34(1):42-69. PubMed ID: 9028916
[TBL] [Abstract][Full Text] [Related]
28. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells.
Smith MT; Evans CG; Doane-Setzer P; Castro VM; Tahir MK; Mannervik B
Cancer Res; 1989 May; 49(10):2621-5. PubMed ID: 2713846
[TBL] [Abstract][Full Text] [Related]
29. Antineoplastic activities of alpha-, beta-, and gamma-alkylaminopropiophenone derivatives in mice and in murine and human tissue culture cells.
Huang Y; Hall IH
Anticancer Res; 1996; 16(2):597-604. PubMed ID: 8687103
[TBL] [Abstract][Full Text] [Related]
30. Preclinical studies and clinical correlation of the effect of alkylating dose.
Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
[TBL] [Abstract][Full Text] [Related]
31. Growth kinetics and treatment response of the intracerebral rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging.
Kim B; Chenevert TL; Ross BD
Clin Cancer Res; 1995 Jun; 1(6):643-50. PubMed ID: 9816027
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
33. Cell cycle age response of 9L cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and modification by alpha-difluoromethylornithine.
Bjerkvig R; Oredsson SM; Marton LJ; Linden M; Deen DF
Cancer Res; 1983 Apr; 43(4):1497-500. PubMed ID: 6403224
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
[TBL] [Abstract][Full Text] [Related]
35. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
36. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS
Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic studies of chloroethylnitrosocarbamoyl-amino acid derivatives in vivo and in vitro.
Matthew AM; Bibby MC; Eisenbrand G
Anticancer Res; 1993; 13(1):81-6. PubMed ID: 8476230
[TBL] [Abstract][Full Text] [Related]
38. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
[TBL] [Abstract][Full Text] [Related]
39. Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells.
Horvath Z; Höchtl T; Bauer W; Fritzer-Szekeres M; Elford HL; Szekeres T; Tihan T
Cancer Chemother Pharmacol; 2004 Aug; 54(2):139-45. PubMed ID: 15133626
[TBL] [Abstract][Full Text] [Related]
40. Decreased cytotoxicity of 1-beta-D-arabinofuranosylcytosine in 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine in vitro.
Oredsson SM; Gray JW; Deen DF; Marton LJ
Cancer Res; 1983 Jun; 43(6):2541-4. PubMed ID: 6406046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
